AR056720A1 - SUBSTTED TIAZOL COMPOSITE PHARMACEUTICALLY COMPOSITION THAT INCLUDES IT AND ITS USE TO PREPARE A MEDICINAL PRODUCT - Google Patents
SUBSTTED TIAZOL COMPOSITE PHARMACEUTICALLY COMPOSITION THAT INCLUDES IT AND ITS USE TO PREPARE A MEDICINAL PRODUCTInfo
- Publication number
- AR056720A1 AR056720A1 ARP060104641A ARP060104641A AR056720A1 AR 056720 A1 AR056720 A1 AR 056720A1 AR P060104641 A ARP060104641 A AR P060104641A AR P060104641 A ARP060104641 A AR P060104641A AR 056720 A1 AR056720 A1 AR 056720A1
- Authority
- AR
- Argentina
- Prior art keywords
- prepare
- substted
- tiazol
- composite
- medicinal product
- Prior art date
Links
- 239000002131 composite material Substances 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 206010020853 Hypertonic bladder Diseases 0.000 abstract 2
- 208000009722 Overactive Urinary Bladder Diseases 0.000 abstract 2
- 208000020629 overactive bladder Diseases 0.000 abstract 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical group FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000000460 chlorine Chemical group 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Chemical group 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- -1 thiazole compound Chemical class 0.000 abstract 1
- 230000002485 urinary effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Un compuesto de tiazol substituido de formula (1) en la que: R1 es etilo, propilo o isopropilo y R2 es hidrogeno, cloro, fluor o metilo; o una sal farmacéuticamente aceptable de los mismos. Los compuestos son agentes de apertura de canales de K activados por calcio de alta conductancia (canales Bkca), de interés en el campo de las afecciones urinarias. Composicion farmacéutica que lo comprende y su uso para preparar un medicamento util para tratar la vejiga hiperactiva (OAB).A substituted thiazole compound of formula (1) in which: R1 is ethyl, propyl or isopropyl and R2 is hydrogen, chlorine, fluorine or methyl; or a pharmaceutically acceptable salt thereof. The compounds are K channel opening agents activated by high conductance calcium (Bkca channels), of interest in the field of urinary disorders. Pharmaceutical composition that comprises it and its use to prepare a useful medication to treat overactive bladder (OAB).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73029805P | 2005-10-26 | 2005-10-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR056720A1 true AR056720A1 (en) | 2007-10-17 |
Family
ID=37968661
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP060104641A AR056720A1 (en) | 2005-10-26 | 2006-10-24 | SUBSTTED TIAZOL COMPOSITE PHARMACEUTICALLY COMPOSITION THAT INCLUDES IT AND ITS USE TO PREPARE A MEDICINAL PRODUCT |
Country Status (4)
| Country | Link |
|---|---|
| AR (1) | AR056720A1 (en) |
| PE (1) | PE20070530A1 (en) |
| TW (1) | TW200732314A (en) |
| WO (1) | WO2007051133A2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5277256B2 (en) | 2008-04-09 | 2013-08-28 | 田辺三菱製薬株式会社 | Pyrimidine, pyridine and triazine derivatives as maxi-K channel openers |
| WO2022075780A1 (en) * | 2020-10-07 | 2022-04-14 | 광주과학기술원 | Pharmaceutical composition for preventing or treating overactive bladder |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4746741A (en) * | 1986-06-19 | 1988-05-24 | Eastman Kodak Company | N,N'-bis[2-(3-methylphenyl)ethyl]-perylene-3,4:9,10-bis (dicarboximide) compound use thereof in multi-active photoconductive insulating elements exhibiting far red sensitivity |
| IE73235B1 (en) * | 1991-03-25 | 1997-05-21 | Akzo Nv | 4-aryl-thiazole or imidazole derivatives |
| HU208429B (en) * | 1991-05-03 | 1993-10-28 | Gyogyszerkutato Intezet | Process for producing 1-/3-chloro-phenyl/-4-methyl-7,8-dimethoxy-5h-2,3-benzodiazepine of high purity |
| US5668286A (en) * | 1994-03-15 | 1997-09-16 | Pharmacia & Upjohn Company | Oxazolidinone derivatives and pharmaceutical compositions containing them |
| NZ529043A (en) * | 2001-04-16 | 2006-11-30 | Tanabe Seiyaku Co | Large conductance calcium-activated K channel opener |
| GB0121033D0 (en) * | 2001-08-30 | 2001-10-24 | Novartis Ag | Organic compounds |
| US7057040B2 (en) * | 2002-02-07 | 2006-06-06 | Council Of Scientific And Industrial Research | Substituted aryl alkenoic acid heterocyclic amides |
-
2006
- 2006-10-24 PE PE2006001294A patent/PE20070530A1/en not_active Application Discontinuation
- 2006-10-24 TW TW095139076A patent/TW200732314A/en unknown
- 2006-10-24 AR ARP060104641A patent/AR056720A1/en not_active Application Discontinuation
- 2006-10-26 WO PCT/US2006/060248 patent/WO2007051133A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007051133A3 (en) | 2007-12-13 |
| WO2007051133A2 (en) | 2007-05-03 |
| TW200732314A (en) | 2007-09-01 |
| PE20070530A1 (en) | 2007-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200401194A1 (en) | Glucosocorticoid Mimetics, Methods for Their Production, Pharmaceutical Compositions and Their Use | |
| PE20091556A1 (en) | FUSED HETEROCYCLIC DERIVATIVE AND ITS USE | |
| PA8591701A1 (en) | PIRROLOPIRIMIDINE DERIVATIVES | |
| ES2422557T3 (en) | Compounds and compositions as modulators of the Hedgehog route | |
| CL2007001918A1 (en) | SUBSTITUTED HETEROARILY DERIVATIVE COMPOUNDS; METHOD FOR THE PREPARATION OF COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF PAIN, DEPRESSION, ALZHEIMER'S DISEASE AND HYPERTENSION BETWEEN OTHERS. | |
| GT200600163A (en) | NEW THERAPEUTIC COMBINATIONS FOR THE TREATMENT OR PREVENTION OF DEPRESSION | |
| HN2004000319A (en) | "{1,8} NAFTIRIDIN-2-ONAS AND RELATED COMPOUNDS FOR THE TREATMENT OF CHICHOPHRENIA" | |
| BRPI0417717A (en) | compound, pharmaceutical composition, and use of a compound | |
| ECSP088499A (en) | NEW COMPOUNDS OF 2-AMINO-IMIDAZOL-4-ONA AND ITS USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT FOR USE IN THE TREATMENT OF COGNITIVE ALTERATION, ALZHEIMER'S DISEASE, NEURODEGENERATION AND DEMENTIA | |
| EA200702498A1 (en) | N- (PYRIDIN-2-IL) SULPHONAMIDE DERIVATIVES | |
| EA200971081A1 (en) | PURINUM DERIVATIVES AND THEIR APPLICATION AS A TALL-SIMILAR RECEPTOR MODULATORS 7 | |
| CL2008001868A1 (en) | COMPOUNDS DERIVED FROM N- (2- (HETARIL) ARIL) ARILSULPHONAMIDS AND N- (2- (HETARIL) HETARIL) ARILSULFONAMIDS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE INTESTINE, ALLERGIC DISEASE | |
| DK1697371T3 (en) | Azabicyclic heterocyclic compounds as cannabinoid receptor modulators | |
| UY29825A1 (en) | SUBSTITUTED DERIVATIVES OF 3H-IMIDAZOL- (4.5 B (BETA)) PIRIDINA-2-IL BENZOATES AND BENZAMIDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS | |
| GT200900283A (en) | "COMBINATION THERAPY WITH A COMPOUND ACTING AS AN ADP PLAQUETARY RECEPTOR INHIBITOR". | |
| UY30414A1 (en) | METHANE SULFONATES, PROPANE-1-SULPHONATES AND CYCLOPROPAN SULPHONATES REPLACED WITH [2,3,4,8-TETRAHYDROIMIDAZO- [1,5-AL-PYRIMIDIN-8-IL] -PHENYLL, PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS. | |
| BRPI0611705A2 (en) | compound or a pharmaceutically acceptable salt thereof, pharmaceutical composition, and use of compound | |
| AR063118A1 (en) | DERIVATIVES OF SULFONAMIDE-PIPERIDINE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USES IN ALLERGIC AND RESPIRATORY INFLAMMATORY DISEASES AND DISORDERS | |
| ATE384058T1 (en) | THIAZOLE DERIVATIVES | |
| CL2004000918A1 (en) | COMPOUNDS DERIVED FROM QUINUCLIDINA, ANTAGONISTS OF THE M3 MUSCARINIC RECEIVER; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND USE OF THE COMPOUND TO TREAT AN ANTI-INFLAMMATORY OR ALLERGIC CONDITION, IN PARTICULAR OF THE RESPIRATORY ROADS | |
| CL2007000789A1 (en) | Malonamide derived compounds, gamma-secretase inhibitors; Preparation process; pharmaceutical composition; and its use in the treatment of Alzheimer's disease. | |
| DE60322412D1 (en) | Pharmaceutical solid dispersions of modafinil compounds | |
| GT200500309A (en) | DERIVATIVES OF SULFONILBENCILIMIDAZOL | |
| UY29085A1 (en) | PIRIMIDINE DERIVATIVES 4-SULFONAMID SUBSTITUTED, INTERMEDIATE COMPOUNDS FOR PREPARATION, PREPARATION PROCEDURES, MEDICINAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS | |
| HN2003000379A (en) | USEFUL ANILINOPIRAZOL DERIVATIVES IN THE TREATMENT OF DIABETES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |